Unique ID issued by UMIN | UMIN000023927 |
---|---|
Receipt number | R000027520 |
Scientific Title | Effect of fragmented Lactobacillus amylovotus CP1563 on substrate oxidation and energy expenditure: a randomized cross-over trial |
Date of disclosure of the study information | 2016/09/04 |
Last modified on | 2017/09/15 10:03:27 |
Effect of fragmented Lactobacillus amylovotus CP1563 on substrate oxidation and energy expenditure: a randomized cross-over trial
Effect of fragmented Lactobacillus amylovotus CP1563 on energy metabolism
Effect of fragmented Lactobacillus amylovotus CP1563 on substrate oxidation and energy expenditure: a randomized cross-over trial
Effect of fragmented Lactobacillus amylovotus CP1563 on energy metabolism
Japan |
Not applicable
Adult |
Others
NO
To explore effect of fragmented lactobacillus amylovorus CP1563 on energy expenditure and substrate oxidation.
Efficacy
Energy expenditure, Fat oxidation
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
NO
2
Prevention
Food |
Ingestion of Lactobacillus amylovorus CP1563for 3 weeks, Wash out 1 week and ingestion of Placebo for 3 weeks.
Ingestion of placebo for 3 weeks, Wash out 1 week and ingestion of Lactobacillus amylovorus CP1563 for 3 weeks.
20 | years-old | <= |
50 | years-old | > |
Male
1) Subjects who can make self-judgment and are voluntarily giving written informed consent.
2) Males whose age 40 to 59 years old for Japanese.
1. Subjects who have diabetes in the second degree.
2. Subjects who have past surgical historyof gastroenterological surgery.
3. Subjects who use pharmaceuticals regularly.
4. Subjects who have an acute disease like a inflammation of the upper airway or acute gastroenteritis.
5. Subjects who excessive alcohol intake
and who have a smoking habit.
6. Subjects with allergies of lactobacillus, milk, soy and citrus.
7. Subjects who is irregular eating habits.
8. Subjects who are participating or will participate other clinical trials.
9. Others who have been determined ineligible by principal investigator or subinvestigator.
15
1st name | |
Middle name | |
Last name | Hiroaki Tanaka |
Fukuoka univercity
Faculty of Sports and Health Science
8-19-1, Nanakuma, Jonan-ku, Fukuoka City, Fukuoka, 814-0180, Japan
+81-92-871-6631
htanaka@fukuoka-u.ac.jp
1st name | |
Middle name | |
Last name | Yoichi Hatamoto |
Fukuoka univercity
Faculty of Sports and Health Science
8-19-1, Nanakuma, Jonan-ku, Fukuoka City, Fukuoka, 814-0180, Japan
+81-92-871-6631
y.hatamoto.7@gmail.com
Fukuoka university
Asahi Holdings
Profit organization
NO
2016 | Year | 09 | Month | 04 | Day |
Unpublished
2016 | Year | 07 | Month | 01 | Day |
2016 | Year | 08 | Month | 01 | Day |
2016 | Year | 09 | Month | 04 | Day |
2017 | Year | 09 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027520
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |